Management Of Stoma In Patients Younger Than 3 Months Old
STOMP
Management of Ostomy in Neonates: A Retrospective Single-Center Study
1 other identifier
observational
82
1 country
1
Brief Summary
Indications for jejunostomy, ileostomy or colostomy vary in the neonatal population. The most common etiologies are congenital anomalies, such as anorectal malformations, intestinal atresia or Hirschsprung's disease, but also acquired conditions, such as enterocolitis or intestinal perforation. The aim of these stomas is to divert stool in the event of intestinal obstruction or risk of fecal contamination. Depending on the indication and the type of stoma used, the post-operative follow-up, such as resumption of intestinal transit and feeding, secondary closure of the stoma or not, and the duration and cost of hospitalization differ. The aim of this study is to compare these differences in order to extract an optimal management strategy, in the light of what is reported in the international scientific literature.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 30, 2024
CompletedFirst Submitted
Initial submission to the registry
June 5, 2024
CompletedFirst Posted
Study publicly available on registry
June 14, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 15, 2024
CompletedJune 14, 2024
April 1, 2024
1 month
June 5, 2024
June 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Postoperative medical complications
infections, sepsis, dehydration, hydroelectrolytic disorders
through study completion, an average of 1 year
Postoperative surgical complications
disunion, surgical scar,
through study completion, an average of 1 year
Secondary Outcomes (2)
Length of stay
through study completion, an average of 1 year
Hospitalization costs
through study completion, an average of 1 year
Other Outcomes (1)
Redo
through study completion, an average of 1 year
Study Arms (5)
Hirschsprung's Disease
Patients with Hirschsprung's Disease who had a stoma in the first 3 months of life
Anorectal MAlformations
Patients with Anorectal MAlformations who had a stoma in the first 3 months of life
Intestinal Atresia
Patients with Intestinal Atresia who had a stoma in the first 3 months of life
Necrotizing Enterocolitis
Patients with Necrotizing Enterocolitis who had a stoma in the first 3 months of life
Intestinal Perforations
Patients with Intestinal Perforations who had a stoma in the first 3 months of life
Eligibility Criteria
Neonates whose disease require a stoma during the first 3 months of life, from January 2009 to December 2023
You may qualify if:
- Patients who had a stoma during the first 3 months of life, from January 2009 to December 2023
You may not qualify if:
- Patients who had a stoma after the first 3 months of life, from January 2009 to December 2023
- Patients without a stoma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clermont-Ferrand University Hospital
Clermont-Ferrand, Auvergne, 63000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Christelle Destinval, MD
University Hospital, Clermont-Ferrand
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 5, 2024
First Posted
June 14, 2024
Study Start
May 30, 2024
Primary Completion
June 30, 2024
Study Completion
July 15, 2024
Last Updated
June 14, 2024
Record last verified: 2024-04